BRCA2 mutations in hereditary breast and ovarian cancer in France

被引：0
作者：
SerovaSinilnikova, OM
Boutrand, L
StoppaLyonnet, D
BressacdePaillerets, B
Dubois, V
Lasset, C
Janin, N
Bignon, YJ
Longy, M
Maugard, C
Lidereau, R
Leroux, D
Frebourg, T
Mazoyer, S
Lenoir, GM
机构：
[1] CTR INT RECH CANC,F-69372 LYON 08,FRANCE
[2] CNRS,GENET LAB,UMR5641,LYON,FRANCE
[3] HOP EDOUARD HERRIOT,LYON,FRANCE
[4] CTR LEON BERARD,F-69373 LYON,FRANCE
[5] INST CURIE,PARIS,FRANCE
[6] INST GUSTAVE ROUSSY,VILLEJUIF,FRANCE
[7] CTR JEAN PERRIN,CLERMONT FERRAN,FRANCE
[8] CTR RENE GAUDUCHEAU,F-44035 NANTES,FRANCE
[9] INST BERGONIE,BORDEAUX,FRANCE
[10] CTR RENE HUGUENIN,ST CLOUD,FRANCE
[11] CHU GRENOBLE,F-38043 GRENOBLE,FRANCE
[12] CHR ROUEN,HOP CHARLES NICOLLE,ROUEN,FRANCE
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 1997年 / 60卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：1236 / 1239
页数：4
相关论文
共 50 条
[21]   Hereditary Breast and Ovarian Cancer Syndrome: Moving Beyond BRCA1 and BRCA2 [J].
Hoang, Lien N. ;
Gilks, Blake C. .
ADVANCES IN ANATOMIC PATHOLOGY, 2018, 25 (02) :85-95
[22]   Pathology of hereditary breast cancer in patients with BRCA1, BRCA2 & BRCAX mutations [J].
Lakhani, SR ;
Jacquemier, J ;
Sloane, JP ;
Gusterson, BA ;
Anderson, TJ ;
van de Vijver, MJ ;
Farid, LM ;
Venter, D ;
Easton, DF ;
Stratton, MR .
LABORATORY INVESTIGATION, 1999, 79 (01) :25A-25A
[23]   Prognostic significance of germline BRCA2 mutations in hereditary breast cancer patients [J].
Verhoog, LC ;
Berns, EMJJ ;
Brekelmans, CTM ;
Seynaeve, C ;
Meijers-Heijboer, EJ ;
Klijn, JGM .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (21) :119S-124S
[24]   Hereditary breast and ovarian cancer in Asia:: Genetic epidemiology of BRCA1 and BRCA2 [J].
Liede, A ;
Narod, SA .
HUMAN MUTATION, 2002, 20 (06) :413-424
[25]   BRCA1 and BRCA2 genes:: Role in hereditary breast and ovarian cancer in Italy [J].
Santarosa, M ;
Dolcetti, R ;
Magri, MD ;
Crivellari, D ;
Tibiletti, MG ;
Gallo, A ;
Tumolo, S ;
Della Puppa, L ;
Furlan, D ;
Boiocchi, M ;
Viel, A .
INTERNATIONAL JOURNAL OF CANCER, 1999, 83 (01) :5-9
[26]   Hereditary breast and ovarian cancer in Cyprus:: identification of a founder BRCA2 mutation [J].
Hadjisavvas, A ;
Charalambous, E ;
Adamou, AB ;
Neuhausen, SL ;
Christodoulou, CG ;
Kyriacou, K .
CANCER GENETICS AND CYTOGENETICS, 2004, 151 (02) :152-156
[27]   BRCA1 and BRCA2 Mutations in Ovarian Cancer [J].
Swisher, Elizabeth ;
Walsh, Tom .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (04) :359-360
[28]   BRCA2 mutations in primary breast and ovarian cancers [J].
Lancaster, JM ;
Wooster, R ;
Mangion, J ;
Phelan, CM ;
Cochran, C ;
Gumbs, C ;
Seal, S ;
Barfoot, R ;
Collins, N ;
Bignell, G ;
Patel, S ;
Hamoudi, R ;
Larsson, C ;
Wiseman, RW ;
Berchuck, A ;
Iglehart, JD ;
Marks, JR ;
Ashworth, A ;
Stratton, MR ;
Futreal, PA .
NATURE GENETICS, 1996, 13 (02) :238-240
[29]   BRCA1 and BRCA2 in hereditary breast cancer [J].
Scully, R ;
Puget, N .
BIOCHIMIE, 2002, 84 (01) :95-102
[30]   BRCA1 and BRCA2 gene mutations in hereditary and sporadic ovarian cancer and the clinical implications [J].
Farghaly, SA .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 179 (04) :1101-1101
12345